TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
69
|
107
|
73 |
| Financial expenses |
10
|
38
|
40 |
| Earnings before taxes |
-10
|
8
|
6 |
| EBITDA |
-1
|
46
|
45 |
| Total assets |
1,281
|
1,276
|
1,418 |
| Current assets |
67
|
99
|
88 |
| Current liabilities |
23
|
33
|
25 |
| Equity capital |
1,253
|
1,234
|
1,381 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
97.8%
|
96.7%
|
97.4% |
| Turnover per employee |
69
|
107
|
73 |
| Profit as a percentage of turnover |
-14.5%
|
7.5%
|
8.2% |
| Return on assets (ROA) |
0%
|
3.6%
|
3.2% |
| Current ratio |
291.3%
|
300%
|
352.0% |
| Return on equity (ROE) |
-0.8%
|
0.6%
|
0.4% |
| Change turnover |
-42
|
41
|
28 |
| Change turnover % |
-38%
|
62%
|
61% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.